SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-188298
Filing Date
2014-05-08
Accepted
2014-05-08 06:08:16
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d699858d10q.htm 10-Q 290114
2 EX-31.1 d699858dex311.htm EX-31.1 8126
3 EX-31.2 d699858dex312.htm EX-31.2 8172
4 EX-32.1 d699858dex321.htm EX-32.1 4532
  Complete submission text file 0001193125-14-188298.txt   3207445

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT omed-20140331.xml EX-101.INS 401635
6 XBRL TAXONOMY EXTENSION SCHEMA omed-20140331.xsd EX-101.SCH 40853
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE omed-20140331_cal.xml EX-101.CAL 47226
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omed-20140331_def.xml EX-101.DEF 127564
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE omed-20140331_lab.xml EX-101.LAB 313171
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omed-20140331_pre.xml EX-101.PRE 220787
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Filer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35993 | Film No.: 14822844
SIC: 2834 Pharmaceutical Preparations